Thrombosis Update (Aug 2022)

The mechanistic basis linking cytokine storm to thrombosis in COVID-19

  • Adam Wolf,
  • Faria Khimani,
  • Braian Yoon,
  • Coltin Gerhart,
  • Dakota Endsley,
  • Anish K. Ray,
  • Angelito F. Yango,
  • Stuart D. Flynn,
  • Gregory Y.H. Lip,
  • Stevan A. Gonzalez,
  • Mohanakrishnan Sathyamoorthy

Journal volume & issue
Vol. 8
p. 100110

Abstract

Read online

It is now well established that infection with SARS-CoV-2 resulting in COVID-19 disease includes a severely symptomatic subset of patients in whom an aggressive and/or dysregulated host immune response leads to cytokine storm syndrome (CSS) that may be further complicated by thrombotic events, contributing to the severe morbidity and mortality observed in COVID-19. This review provides a brief overview of cytokine storm in COVID-19, and then presents a mechanistic discussion of how cytokine storm affects integrated pathways in thrombosis involving the endothelium, platelets, the coagulation cascade, eicosanoids, auto-antibody mediated thrombosis, and the fibrinolytic system.

Keywords